董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Thomas F. Frist III | 男 | Chairman | 57 | 39.99万美元 | 1.35 | 2025-07-15 |
| Samuel N. Hazen | 男 | Chief Executive Officer and Director | 66 | 2379.91万美元 | 216.20 | 2025-07-15 |
| Andrea B. Smith | 女 | Director | 57 | 33.18万美元 | 0.36 | 2025-07-15 |
| Michael W. Michelson | 男 | Director | 74 | 38.98万美元 | 1.05 | 2025-07-15 |
| Wayne J. Riley | 男 | Director | 65 | 35.00万美元 | 1.39 | 2025-07-15 |
| Robert J. Dennis | 男 | Director | 71 | 34.49万美元 | 2.56 | 2025-07-15 |
| Hugh F. Johnston | 男 | Director | 63 | 34.00万美元 | 0.26 | 2025-07-15 |
| William R. Frist | 男 | Director | 56 | 30.99万美元 | 41.76 | 2025-07-15 |
| Nancy Ann M. DeParle | 女 | Director | 68 | 33.50万美元 | 2.08 | 2025-07-15 |
| John W. Chidsey | 男 | Director | 62 | 未披露 | 未持股 | 2025-07-15 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Samuel N. Hazen | 男 | Chief Executive Officer and Director | 66 | 2379.91万美元 | 216.20 | 2025-07-15 |
| Michael S. Cuffe | 男 | Executive Vice President and Chief Clinical Officer | 59 | 554.13万美元 | 7.97 | 2025-07-15 |
| Christopher F. Wyatt | 男 | Senior Vice President and Controller | 47 | 未披露 | 未持股 | 2025-07-15 |
| Jennifer L. Berres | 女 | Senior Vice President and Chief Human Resources Officer | 54 | 未披露 | 未持股 | 2025-07-15 |
| Michael R. McAlevey | 男 | Executive Vice President - Chief Legal and Administrative Officer | 61 | 573.88万美元 | 3.83 | 2025-07-15 |
| Sammie S. Mosier | -- | Senior Vice President and Chief Nurse Executive | 50 | 未披露 | 未持股 | 2025-07-15 |
| Michael A. Marks | 男 | Executive Vice President and Chief Financial Officer | 55 | 550.94万美元 | 12.02 | 2025-07-15 |
| Jon M. Foster | 男 | Executive Vice President and Chief Operating Officer | 63 | 917.03万美元 | 29.01 | 2025-07-15 |
董事简历
中英对照 | 中文 | 英文- Thomas F. Frist III
-
Thomas F. Frist III，自2015年12月起担任董事。自2019年4月以来，他曾担任HCA Healthcare，Inc.的董事会主席。自2006年起担任董事。他是first Capital有限责任公司（一家位于田纳西州纳什维尔的投资公司，他于2002年成立，在公共和私人公司进行长期股权投资）的创始人和管理负责人。在此之前，他是FS Partners II，LLC的管理成员，并在Rainwater，Inc.的主要投资部门工作。1992年到1995年。2013年至2017年，他曾担任Science Applications International Corporation的董事。他持有Princeton大学的文学士学位和Harvard Business School的工商管理硕士学位。
Thomas F. Frist III,has served as a director since December 2015. Since April 2019, Mr. Frist has served as Chairman of the Board of Directors of HCA Healthcare, Inc. where he has served as a director since 2006. Mr. Frist is the Founder and Managing Principal of Frist Capital, LLC, an investment firm based in Nashville, Tennessee, which he founded in 2002 that makes long-term equity investments in public and private companies. Prior to that, he was the managing member of FS Partners II, LLC and he worked in principal investments at Rainwater, Inc. from 1992 to 1995. Mr. Frist previously served as a director of Science Applications International Corporation from 2013 until 2017. Mr. Frist holds a B.A. degree from Princeton University and an M.B.A. degree from Harvard Business School. - Thomas F. Frist III，自2015年12月起担任董事。自2019年4月以来，他曾担任HCA Healthcare，Inc.的董事会主席。自2006年起担任董事。他是first Capital有限责任公司（一家位于田纳西州纳什维尔的投资公司，他于2002年成立，在公共和私人公司进行长期股权投资）的创始人和管理负责人。在此之前，他是FS Partners II，LLC的管理成员，并在Rainwater，Inc.的主要投资部门工作。1992年到1995年。2013年至2017年，他曾担任Science Applications International Corporation的董事。他持有Princeton大学的文学士学位和Harvard Business School的工商管理硕士学位。
- Thomas F. Frist III,has served as a director since December 2015. Since April 2019, Mr. Frist has served as Chairman of the Board of Directors of HCA Healthcare, Inc. where he has served as a director since 2006. Mr. Frist is the Founder and Managing Principal of Frist Capital, LLC, an investment firm based in Nashville, Tennessee, which he founded in 2002 that makes long-term equity investments in public and private companies. Prior to that, he was the managing member of FS Partners II, LLC and he worked in principal investments at Rainwater, Inc. from 1992 to 1995. Mr. Frist previously served as a director of Science Applications International Corporation from 2013 until 2017. Mr. Frist holds a B.A. degree from Princeton University and an M.B.A. degree from Harvard Business School.
- Samuel N. Hazen
-
Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁，从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前，他在不同医院工作，在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
Samuel N. Hazen,has served as Chief Executive Officer since January 2019 and was appointed as a director in September 2018. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — Western Group from 2001 to 2011 and as Chief Financial Officer — Western Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in various hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc. - Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁，从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前，他在不同医院工作，在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
- Samuel N. Hazen,has served as Chief Executive Officer since January 2019 and was appointed as a director in September 2018. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — Western Group from 2001 to 2011 and as Chief Financial Officer — Western Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in various hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.
- Andrea B. Smith
-
Andrea B. Smith，自2015年7月起担任首席行政官；2010年1月至2015年7月担任人力资源主管。
Andrea B. Smith,retired from Bank of America in December 2021 after nearly 34 years with the company. Most recently, she served as chief administrative officer from August 2015 through December 2021. Previously, she led Global Human Resources from January 2010 to August 2015. She has served as interim President and Chief Executive officer of the Charlotte Regional Business Alliance since May 2024. She is also chair of the Bank of America Alumni Network and serves on the boards of several nonprofit organizations, including Every Mother Counts and the Charlotte Sports Foundation. - Andrea B. Smith，自2015年7月起担任首席行政官；2010年1月至2015年7月担任人力资源主管。
- Andrea B. Smith,retired from Bank of America in December 2021 after nearly 34 years with the company. Most recently, she served as chief administrative officer from August 2015 through December 2021. Previously, she led Global Human Resources from January 2010 to August 2015. She has served as interim President and Chief Executive officer of the Charlotte Regional Business Alliance since May 2024. She is also chair of the Bank of America Alumni Network and serves on the boards of several nonprofit organizations, including Every Mother Counts and the Charlotte Sports Foundation.
- Michael W. Michelson
-
Michael W. Michelson，KKR管理有限责任公司高级顾问合伙人，私人股本投资管理公司及KKR有限公司普通合伙人，自2018年1月起至2020年1月退休。此前为KKR管理有限责任公司成员，2009年10月至今。在此之前，Michelson先生是有限责任公司的成员，自1996年以来一直担任Kohlberg Kravis Roberts & Co. L.P.的普通合伙人。1981年加入KKR。Michelson先生在KKR投资组合公司的发展中发挥了重要作用。他的职业生涯始于洛杉矶的Latham & Watkins律师事务所，在那里他参与了广泛的公司业务，同时专门从事管理层收购。他获得了哈佛大学的学士学位和哈佛法学院的法学博士学位。
Michael W. Michelson,was a Senior Advisory Partner of KKR & Co. L.P. from January 2018 to the end of 2019. From 2009 to 2018, he was a member of KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P. Before that, Mr. Michelson was a member of the limited liability company which served as the general partner of KKR & Co. L.P. from 1996 to 2009. Prior to that, he was a general partner of KKR & Co. L.P. Mr. Michelson previously served as a director of the Company from 2006 to 2016. He served as a director of Zimmer Biomet Holdings, Inc., a medical device company, from 2015 to 2024 and was previously a director of Biomet, Inc. from 2007 to 2015. - Michael W. Michelson，KKR管理有限责任公司高级顾问合伙人，私人股本投资管理公司及KKR有限公司普通合伙人，自2018年1月起至2020年1月退休。此前为KKR管理有限责任公司成员，2009年10月至今。在此之前，Michelson先生是有限责任公司的成员，自1996年以来一直担任Kohlberg Kravis Roberts & Co. L.P.的普通合伙人。1981年加入KKR。Michelson先生在KKR投资组合公司的发展中发挥了重要作用。他的职业生涯始于洛杉矶的Latham & Watkins律师事务所，在那里他参与了广泛的公司业务，同时专门从事管理层收购。他获得了哈佛大学的学士学位和哈佛法学院的法学博士学位。
- Michael W. Michelson,was a Senior Advisory Partner of KKR & Co. L.P. from January 2018 to the end of 2019. From 2009 to 2018, he was a member of KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P. Before that, Mr. Michelson was a member of the limited liability company which served as the general partner of KKR & Co. L.P. from 1996 to 2009. Prior to that, he was a general partner of KKR & Co. L.P. Mr. Michelson previously served as a director of the Company from 2006 to 2016. He served as a director of Zimmer Biomet Holdings, Inc., a medical device company, from 2015 to 2024 and was previously a director of Biomet, Inc. from 2007 to 2015.
- Wayne J. Riley
-
Wayne J. Riley，他一直担任SUNY Downstate Health Sciences University的总裁（2017年4月以来），在那里他也是内科和卫生政策与管理的终身教授。从2013年到2017年，他担任范德比尔特大学欧文管理研究生院医疗保健管理兼职教授和范德比尔特大学医学院临床医学教授。从2007年到2013年，他担任Meharry Medical College的总裁兼首席执行官。从2003年到2006年，Riley博士担任Baylor College of Medicine的副总裁兼卫生事务和政府关系副院长。Riley博士自2021年起担任Compass Pathways， plc和HeartFlow， Inc.的董事。Riley博士从2010年到2015年担任Vertex Pharmaceuticals Incorporated的董事，从2007年到2013年担任Pinnacle Financial Partners， Inc.的董事，从2013年1月到2013年6月担任亚特兰大联邦储备委员会纳什维尔分行的董事。他是美国内科医师学会的名誉主席和美国国家医学院的当选成员。他也是医疗保险支付咨询委员会（MedPAC）委员和纽约医学院董事会主席。
Wayne J. Riley,has served as president of SUNY Downstate Health Sciences University since April 2017, where he is also a tenured professor of internal medicine and health policy and management. From 2013 to 2017, he was Adjunct Professor of Healthcare Management, Owen Graduate School of Management, Vanderbilt University and Clinical Professor of Medicine, Vanderbilt University School of Medicine. From 2007 to 2013, he served as President and CEO of Meharry Medical College. From 2003 through 2006, Dr. Riley served as Vice-President and Vice Dean for Health Affairs and Governmental Relations, Baylor College of Medicine. Dr. Riley has also served as a director of Compass Pathways, plc since 2021 and HeartFlow, Inc. since 2021. Dr. Riley served as a director of Vertex Pharmaceuticals Incorporated from 2010 to 2015, Pinnacle Financial Partners, Inc. from 2007 to 2013 and the Federal Reserve Board of Atlanta, Nashville Branch from January 2013 to June 2013. He is President Emeritus of the American College of Physicians and an elected member of the National Academy of Medicine. Dr. Riley is also a Commissioner of the Medicare Payment Advisory Commission (MedPAC) and Chair of the Board of Trustees of The New York Academy of Medicine. - Wayne J. Riley，他一直担任SUNY Downstate Health Sciences University的总裁（2017年4月以来），在那里他也是内科和卫生政策与管理的终身教授。从2013年到2017年，他担任范德比尔特大学欧文管理研究生院医疗保健管理兼职教授和范德比尔特大学医学院临床医学教授。从2007年到2013年，他担任Meharry Medical College的总裁兼首席执行官。从2003年到2006年，Riley博士担任Baylor College of Medicine的副总裁兼卫生事务和政府关系副院长。Riley博士自2021年起担任Compass Pathways， plc和HeartFlow， Inc.的董事。Riley博士从2010年到2015年担任Vertex Pharmaceuticals Incorporated的董事，从2007年到2013年担任Pinnacle Financial Partners， Inc.的董事，从2013年1月到2013年6月担任亚特兰大联邦储备委员会纳什维尔分行的董事。他是美国内科医师学会的名誉主席和美国国家医学院的当选成员。他也是医疗保险支付咨询委员会（MedPAC）委员和纽约医学院董事会主席。
- Wayne J. Riley,has served as president of SUNY Downstate Health Sciences University since April 2017, where he is also a tenured professor of internal medicine and health policy and management. From 2013 to 2017, he was Adjunct Professor of Healthcare Management, Owen Graduate School of Management, Vanderbilt University and Clinical Professor of Medicine, Vanderbilt University School of Medicine. From 2007 to 2013, he served as President and CEO of Meharry Medical College. From 2003 through 2006, Dr. Riley served as Vice-President and Vice Dean for Health Affairs and Governmental Relations, Baylor College of Medicine. Dr. Riley has also served as a director of Compass Pathways, plc since 2021 and HeartFlow, Inc. since 2021. Dr. Riley served as a director of Vertex Pharmaceuticals Incorporated from 2010 to 2015, Pinnacle Financial Partners, Inc. from 2007 to 2013 and the Federal Reserve Board of Atlanta, Nashville Branch from January 2013 to June 2013. He is President Emeritus of the American College of Physicians and an elected member of the National Academy of Medicine. Dr. Riley is also a Commissioner of the Medicare Payment Advisory Commission (MedPAC) and Chair of the Board of Trustees of The New York Academy of Medicine.
- Robert J. Dennis
-
Robert J. Dennis，2013年2月被任命为董事，现为本公司薪酬委员会成员。他是Genesco的董事长、总裁、首席执行官，这是经营鞋帽、运动服装及配件的多元化零售公司，他自2004年起担任经理人员。他在零售业有着27年的丰富经验，曾在Hat World Corporation 和 Asbury Automotive担任过高级职务；也曾是国际咨询公司麦肯锡北美零售业务的合伙人、负责人。他以优异成绩获得了哈佛商学院消费者营销方向的工商管理硕士学位、Rensselaer Polytechnic Institute的学士和硕士学位。截止2014年2月，他是HCA Holdings的董事，这是著名的在美国和英国伦敦经营医院和手术中心的医疗健康服务公司。之前，他曾是Teavana Holdings的董事，该公司经营高品质的茶和茶制品，直到2012年12月它被星巴克收购。目前，他任职于the United Way of Metropolitan Nashville、纳什维尔交响乐队的董事会，以及Vanderbilt University's Owen School of Management的监事会。
Robert J. Dennis,served as Executive Chairman of Genesco Inc., a specialty retailer, from February 2020 until June 2020. Previously, he served as Genesco's President and Chief Executive Officer from 2008 to February 2020 and as Chairman from April 2010 to February 2020. Mr. Dennis served as Genesco's President and Chief Operating Officer from 2006 until 2008, Executive Vice President and Chief Operating Officer from 2005 until 2006 and Senior Vice President from 2004 until 2005. He previously served as Chief Executive Officer of Hat World Corporation from 2001 to 2004. Mr. Dennis has also served as a director of CoreCivic, Inc. since February 2013 and as a director of Teavana Holdings, Inc. from 2011 to 2012. - Robert J. Dennis，2013年2月被任命为董事，现为本公司薪酬委员会成员。他是Genesco的董事长、总裁、首席执行官，这是经营鞋帽、运动服装及配件的多元化零售公司，他自2004年起担任经理人员。他在零售业有着27年的丰富经验，曾在Hat World Corporation 和 Asbury Automotive担任过高级职务；也曾是国际咨询公司麦肯锡北美零售业务的合伙人、负责人。他以优异成绩获得了哈佛商学院消费者营销方向的工商管理硕士学位、Rensselaer Polytechnic Institute的学士和硕士学位。截止2014年2月，他是HCA Holdings的董事，这是著名的在美国和英国伦敦经营医院和手术中心的医疗健康服务公司。之前，他曾是Teavana Holdings的董事，该公司经营高品质的茶和茶制品，直到2012年12月它被星巴克收购。目前，他任职于the United Way of Metropolitan Nashville、纳什维尔交响乐队的董事会，以及Vanderbilt University's Owen School of Management的监事会。
- Robert J. Dennis,served as Executive Chairman of Genesco Inc., a specialty retailer, from February 2020 until June 2020. Previously, he served as Genesco's President and Chief Executive Officer from 2008 to February 2020 and as Chairman from April 2010 to February 2020. Mr. Dennis served as Genesco's President and Chief Operating Officer from 2006 until 2008, Executive Vice President and Chief Operating Officer from 2005 until 2006 and Senior Vice President from 2004 until 2005. He previously served as Chief Executive Officer of Hat World Corporation from 2001 to 2004. Mr. Dennis has also served as a director of CoreCivic, Inc. since February 2013 and as a director of Teavana Holdings, Inc. from 2011 to 2012.
- Hugh F. Johnston
-
Hugh F. Johnston，他于1987年加入百事公司，并担任各种职务，包括百事公司全球运营执行副总裁；百事可乐北美区总裁；百事公司转型高级副总裁；百事饮料和食品公司高级副总裁兼首席财务官；百事公司负责并购的高级副总裁。1999年至2002年，他曾担任Merck & Co.的零售副总裁。Johnston于2010年被任命为百事公司的首席财务官，负责为百事公司提供战略财务领导，包括确保公司的战略为股东创造价值，向投资者传达公司的战略和业绩，实施资本结构，财务流程和控制，以支持公司的增长和投资回报目标。Johnston目前担任Microsoft Corp.的董事会成员和审计委员会主席，以及HCA Healthcare的董事会成员和审计委员会主席。他还是全球领先的经济智库彼得森国际经济研究所（Peterson Institute for International Economics）的主任。他持有Syracuse University的理学学士学位和University of Chicago的工商管理硕士学位。
Hugh F. Johnston was appointed Chief Financial Officer effective December 4, 2023. Prior to joining the Company, he served as Executive Vice President and Chief Financial Officer, from 2010, and Vice Chairman, from 2015 to November 2023 of PepsiCo, Inc. ("PepsiCo"). His portfolio included a variety of responsibilities, including leadership of PepsiCo's information technology function from 2015, PepsiCo's global e commerce biness from 2015 to 2019, and the Quaker Foods North America division from 2014 to 2016. He also held a number of other leadership roles during his PepsiCo career, having served as Executive Vice President, Global Operations from 2009 to 2010, President of Pepsi Cola North America from 2007 to 2009, Executive Vice President, Operations from 2006 to 2007 and Senior Vice President, Transformation from 2005 to 2006. Prior to that, he served as Senior Vice President and Chief Financial Officer of PepsiCo Beverages and Foods from 2002 through 2005, and as PepsiCo's Senior Vice President of Mergers and Acquisitions in 2002. He joined PepsiCo in 1987 as a Biness Planner and held vario finance positions until 1999 when he left to join Merck & Co., Inc. as Vice President, Retail, a position which he held until he rejoined PepsiCo in 2002. Mr. Johnston serves on the board of directors of Microsoft Corporation, which he joined in 2017, and on the board of HCA Healthcare, Inc., which he joined in 2021. - Hugh F. Johnston，他于1987年加入百事公司，并担任各种职务，包括百事公司全球运营执行副总裁；百事可乐北美区总裁；百事公司转型高级副总裁；百事饮料和食品公司高级副总裁兼首席财务官；百事公司负责并购的高级副总裁。1999年至2002年，他曾担任Merck & Co.的零售副总裁。Johnston于2010年被任命为百事公司的首席财务官，负责为百事公司提供战略财务领导，包括确保公司的战略为股东创造价值，向投资者传达公司的战略和业绩，实施资本结构，财务流程和控制，以支持公司的增长和投资回报目标。Johnston目前担任Microsoft Corp.的董事会成员和审计委员会主席，以及HCA Healthcare的董事会成员和审计委员会主席。他还是全球领先的经济智库彼得森国际经济研究所（Peterson Institute for International Economics）的主任。他持有Syracuse University的理学学士学位和University of Chicago的工商管理硕士学位。
- Hugh F. Johnston was appointed Chief Financial Officer effective December 4, 2023. Prior to joining the Company, he served as Executive Vice President and Chief Financial Officer, from 2010, and Vice Chairman, from 2015 to November 2023 of PepsiCo, Inc. ("PepsiCo"). His portfolio included a variety of responsibilities, including leadership of PepsiCo's information technology function from 2015, PepsiCo's global e commerce biness from 2015 to 2019, and the Quaker Foods North America division from 2014 to 2016. He also held a number of other leadership roles during his PepsiCo career, having served as Executive Vice President, Global Operations from 2009 to 2010, President of Pepsi Cola North America from 2007 to 2009, Executive Vice President, Operations from 2006 to 2007 and Senior Vice President, Transformation from 2005 to 2006. Prior to that, he served as Senior Vice President and Chief Financial Officer of PepsiCo Beverages and Foods from 2002 through 2005, and as PepsiCo's Senior Vice President of Mergers and Acquisitions in 2002. He joined PepsiCo in 1987 as a Biness Planner and held vario finance positions until 1999 when he left to join Merck & Co., Inc. as Vice President, Retail, a position which he held until he rejoined PepsiCo in 2002. Mr. Johnston serves on the board of directors of Microsoft Corporation, which he joined in 2017, and on the board of HCA Healthcare, Inc., which he joined in 2021.
- William R. Frist
-
William R. Frist是Frist Capital LLC（Frist先生和某些相关人员的私人投资工具）的负责人，自2003年以来担任该职位。他也是Frisco Partners（另一个Frist家庭投资工具）的普通合伙人。他是Thomas F. Frist III（也是公司的董事）的兄弟。
William R. Frist,is a principal of Champion & Co. Inc., a Nashville-based investment firm, and has held this position since 2023. From 2003 to 2023, Mr. Frist was a principal in Frist Capital, LLC, a Nashville-based investment firm. Mr. Frist currently serves on the Board of Directors of The Frist Foundation and as Chair and President of the Board of Trustees of the Frist Art Museum. - William R. Frist是Frist Capital LLC（Frist先生和某些相关人员的私人投资工具）的负责人，自2003年以来担任该职位。他也是Frisco Partners（另一个Frist家庭投资工具）的普通合伙人。他是Thomas F. Frist III（也是公司的董事）的兄弟。
- William R. Frist,is a principal of Champion & Co. Inc., a Nashville-based investment firm, and has held this position since 2023. From 2003 to 2023, Mr. Frist was a principal in Frist Capital, LLC, a Nashville-based investment firm. Mr. Frist currently serves on the Board of Directors of The Frist Foundation and as Chair and President of the Board of Trustees of the Frist Art Museum.
- Nancy Ann M. DeParle
-
Nancy Ann M. DeParle，她是私募股权公司辅音资本合伙公司的联合创始人，并自2020年1月起担任该公司的管理合伙人。2013年至2019年，她曾担任该公司的合伙人。2009年3月至2013年1月，她在白宫任职，最初担任总统顾问和白宫医疗改革办公室主任，后来担任总统助理和政策副参谋长。2001年至2009年，她曾担任JPMorgan Partners及其继任者CCMP Capital的高级顾问和董事总经理。1993年至2000年，她担任白宫管理和预算办公室卫生和人事副主任，后来担任医疗保险和医疗补助服务中心（当时称为医疗保健融资管理局）的管理员。她还担任CVS Health Corporation的董事（2013年9月以来）。
Nancy Ann M. DeParle,is a co-founder of Consonance Capital Partners, a private equity firm, and has also served as a managing partner of the firm since January 2020. She previously served as a partner of the firm from 2013 to 2019. From March 2009 to January 2013, Ms. DeParle served in the White House, first as Counselor to the President and Director of the White House Office of Health Reform, and later as Assistant to the President and Deputy Chief of Staff for Policy. From 2001 to 2009, Ms. DeParle was a senior advisor and managing director of JPMorgan Partners and its successor, CCMP Capital. From 1993 to 2000, Ms. DeParle served as the Associate Director for Health and Personnel for the White House Office of Management and Budget, and later as the Administrator of the Centers for Medicare and Medicaid Services (then known as the Health Care Financing Administration). Ms. DeParle has also served as a director of CVS Health Corporation since September 2013. - Nancy Ann M. DeParle，她是私募股权公司辅音资本合伙公司的联合创始人，并自2020年1月起担任该公司的管理合伙人。2013年至2019年，她曾担任该公司的合伙人。2009年3月至2013年1月，她在白宫任职，最初担任总统顾问和白宫医疗改革办公室主任，后来担任总统助理和政策副参谋长。2001年至2009年，她曾担任JPMorgan Partners及其继任者CCMP Capital的高级顾问和董事总经理。1993年至2000年，她担任白宫管理和预算办公室卫生和人事副主任，后来担任医疗保险和医疗补助服务中心（当时称为医疗保健融资管理局）的管理员。她还担任CVS Health Corporation的董事（2013年9月以来）。
- Nancy Ann M. DeParle,is a co-founder of Consonance Capital Partners, a private equity firm, and has also served as a managing partner of the firm since January 2020. She previously served as a partner of the firm from 2013 to 2019. From March 2009 to January 2013, Ms. DeParle served in the White House, first as Counselor to the President and Director of the White House Office of Health Reform, and later as Assistant to the President and Deputy Chief of Staff for Policy. From 2001 to 2009, Ms. DeParle was a senior advisor and managing director of JPMorgan Partners and its successor, CCMP Capital. From 1993 to 2000, Ms. DeParle served as the Associate Director for Health and Personnel for the White House Office of Management and Budget, and later as the Administrator of the Centers for Medicare and Medicaid Services (then known as the Health Care Financing Administration). Ms. DeParle has also served as a director of CVS Health Corporation since September 2013.
- John W. Chidsey
-
John W. Chidsey， 2013年4月成为公司董事。他是新成立公司Red Book Connect（协助零售、餐饮和酒店业解决复杂的管理挑战，提高运营效率，通过全面基于云技术平台提高盈利能力）的执行董事长。Chidsey先生早前曾担任Burger King Corporation的董事长和首席执行官。在被任命为首席执行官之前，他担任的是总裁和首席财务官；在那之前，担任美洲地区资产和北美地区资产。在他2004年3月被Burger King Corporation聘用之前，Chidsey先生担任了Cendant两个公司分部的董事长和首席执行官： the Vehicle Services Division， 一个59亿美元的分部，包含了Avis Rent A Car, Budget Rent A Car Systems, PHH和Wright Express；the Financial Services Division， 一个14亿美元的分部，包含了Jackson Hewitt。 他于1996年加入Cendant，担任优选联盟（Preferred Alliances）的高级副总裁。1992年至1995年，Chidsey先生在Pepsi担任多个高管职位，包括Pepsi-Cola Eastern Europe的财务董事和PepsiCo World Trading Co., Inc.的首席财务官。Chidsey先生拥有Emory University的金融学和会计学工商管理硕士学位和法学博士学位，以及Davidson College的学士学位。他是佐治亚州亚特兰大Instawares Holding Company的董事，和阿拉巴马州伯明翰HealthSouth的董事，以及北卡罗来纳州戴维森Davidson College的理事。Chidsey先生是一名注册会计师和Georgia Bar Association的成员。
John W. Chidsey is the chief executive officer of Subway Restaurants. Prior to joining Subway in November 2019 he served as an executive board member of TopTech Holdings, LLC, a provider of comprehensive cloud-based technology with expertise in hiring, training, scheduling, back office and standardization, prior to the sale of that company in August 2019. From the time of the October 2010 sale of Burger King Holdings, Inc. to 3G Capital until April 18 2011 Mr. Chidsey served as co-chairman of the board of directors of Burger King Holdings, Inc. Before the sale, he served as chief executive officer and a member of its board from April 2006 including as chairman of the board from July 2008. From September 2005 until April 2006 he served as president and chief financial officer. He served as president, North America, from June 2004 to September 2005 and as executive vice president, chief administrative and financial officer from March 2004 until June 2004. Prior to joining Burger King, Mr. Chidsey served as chairman and chief executive officer for two corporate divisions of Cendant Corporation: the Vehicle Services Division that included Avis Rent A Car, Budget Rent A Car Systems, PHH and Wright Express and the Financial Services Division that included Jackson Hewitt and various membership and insurance companies. Mr. Chidsey currently serves on the board and the audit and compensation committees of Norwegian Cruise Line Holdings Ltd. He recently served as a director of Brinker International, Inc. - John W. Chidsey， 2013年4月成为公司董事。他是新成立公司Red Book Connect（协助零售、餐饮和酒店业解决复杂的管理挑战，提高运营效率，通过全面基于云技术平台提高盈利能力）的执行董事长。Chidsey先生早前曾担任Burger King Corporation的董事长和首席执行官。在被任命为首席执行官之前，他担任的是总裁和首席财务官；在那之前，担任美洲地区资产和北美地区资产。在他2004年3月被Burger King Corporation聘用之前，Chidsey先生担任了Cendant两个公司分部的董事长和首席执行官： the Vehicle Services Division， 一个59亿美元的分部，包含了Avis Rent A Car, Budget Rent A Car Systems, PHH和Wright Express；the Financial Services Division， 一个14亿美元的分部，包含了Jackson Hewitt。 他于1996年加入Cendant，担任优选联盟（Preferred Alliances）的高级副总裁。1992年至1995年，Chidsey先生在Pepsi担任多个高管职位，包括Pepsi-Cola Eastern Europe的财务董事和PepsiCo World Trading Co., Inc.的首席财务官。Chidsey先生拥有Emory University的金融学和会计学工商管理硕士学位和法学博士学位，以及Davidson College的学士学位。他是佐治亚州亚特兰大Instawares Holding Company的董事，和阿拉巴马州伯明翰HealthSouth的董事，以及北卡罗来纳州戴维森Davidson College的理事。Chidsey先生是一名注册会计师和Georgia Bar Association的成员。
- John W. Chidsey is the chief executive officer of Subway Restaurants. Prior to joining Subway in November 2019 he served as an executive board member of TopTech Holdings, LLC, a provider of comprehensive cloud-based technology with expertise in hiring, training, scheduling, back office and standardization, prior to the sale of that company in August 2019. From the time of the October 2010 sale of Burger King Holdings, Inc. to 3G Capital until April 18 2011 Mr. Chidsey served as co-chairman of the board of directors of Burger King Holdings, Inc. Before the sale, he served as chief executive officer and a member of its board from April 2006 including as chairman of the board from July 2008. From September 2005 until April 2006 he served as president and chief financial officer. He served as president, North America, from June 2004 to September 2005 and as executive vice president, chief administrative and financial officer from March 2004 until June 2004. Prior to joining Burger King, Mr. Chidsey served as chairman and chief executive officer for two corporate divisions of Cendant Corporation: the Vehicle Services Division that included Avis Rent A Car, Budget Rent A Car Systems, PHH and Wright Express and the Financial Services Division that included Jackson Hewitt and various membership and insurance companies. Mr. Chidsey currently serves on the board and the audit and compensation committees of Norwegian Cruise Line Holdings Ltd. He recently served as a director of Brinker International, Inc.
高管简历
中英对照 | 中文 | 英文- Samuel N. Hazen
Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁，从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前，他在不同医院工作，在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
Samuel N. Hazen,has served as Chief Executive Officer since January 2019 and was appointed as a director in September 2018. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — Western Group from 2001 to 2011 and as Chief Financial Officer — Western Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in various hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.- Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁，从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前，他在不同医院工作，在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
- Samuel N. Hazen,has served as Chief Executive Officer since January 2019 and was appointed as a director in September 2018. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — Western Group from 2001 to 2011 and as Chief Financial Officer — Western Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in various hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.
- Michael S. Cuffe
Michael S. Cuffe，自2022年1月1日起被任命为执行副总裁兼首席临床官。2011年10月至2021年12月，他曾担任内科服务集团总裁。从2011年10月到2015年1月，他还担任公司的副总裁。在此之前，他从2011年3月到2011年10月担任Duke University Health System的门诊服务副总裁和首席医疗官，从2005年6月到2011年3月担任医疗事务副总裁。2008年6月至2011年3月，他还担任杜克大学医学院医学事务副院长，2009年8月至2010年8月担任医学系副主任，2005年3月至2011年10月担任医学副教授。在此之前，他曾担任杜克临床研究所、杜克大学医学中心和杜克大学医学院的各种领导职务。
Michael S. Cuffe,was appointed Executive Vice President and Chief Clinical Officer effective January 1, 2022. He previously served as President — Physician Services Group from October 2011 through December 2021. From October 2011 to January 2015, Dr. Cuffe also served as a Vice President of the Company. Prior to that time, Dr. Cuffe served Duke University Health System as Vice President for Ambulatory Services and Chief Medical Officer from March 2011 to October 2011 and Vice President Medical Affairs from June 2005 to March 2011. He also served Duke University School of Medicine as Vice Dean for Medical Affairs from June 2008 to March 2011, Deputy Chair of the Department of Medicine from August 2009 to August 2010 and Associate Professor of Medicine from March 2005 to October 2011. Prior that time, Dr. Cuffe served in various leadership roles with the Duke Clinical Research Institute, Duke University Medical Center and Duke University School of Medicine.- Michael S. Cuffe，自2022年1月1日起被任命为执行副总裁兼首席临床官。2011年10月至2021年12月，他曾担任内科服务集团总裁。从2011年10月到2015年1月，他还担任公司的副总裁。在此之前，他从2011年3月到2011年10月担任Duke University Health System的门诊服务副总裁和首席医疗官，从2005年6月到2011年3月担任医疗事务副总裁。2008年6月至2011年3月，他还担任杜克大学医学院医学事务副院长，2009年8月至2010年8月担任医学系副主任，2005年3月至2011年10月担任医学副教授。在此之前，他曾担任杜克临床研究所、杜克大学医学中心和杜克大学医学院的各种领导职务。
- Michael S. Cuffe,was appointed Executive Vice President and Chief Clinical Officer effective January 1, 2022. He previously served as President — Physician Services Group from October 2011 through December 2021. From October 2011 to January 2015, Dr. Cuffe also served as a Vice President of the Company. Prior to that time, Dr. Cuffe served Duke University Health System as Vice President for Ambulatory Services and Chief Medical Officer from March 2011 to October 2011 and Vice President Medical Affairs from June 2005 to March 2011. He also served Duke University School of Medicine as Vice Dean for Medical Affairs from June 2008 to March 2011, Deputy Chair of the Department of Medicine from August 2009 to August 2010 and Associate Professor of Medicine from March 2005 to October 2011. Prior that time, Dr. Cuffe served in various leadership roles with the Duke Clinical Research Institute, Duke University Medical Center and Duke University School of Medicine.
- Christopher F. Wyatt
Christopher F. Wyatt，他于2016年4月被任命为高级副总裁兼总会计师。此前，他曾担任公司的副总裁兼首席财务官，负责信息技术（从2013年1月到2016年4月），以及临床服务集团的首席财务官（从2010年10月到2013年1月）。从2000年到2010年，他曾担任安永会计师事务所（Ernst & Young）的多种职务。
Christopher F. Wyatt,was appointed Senior Vice President and Controller in April 2016. Prior to that time, Mr. Wyatt served the Company as Vice President and Chief Financial Officer — IT&S from January 2013 to April 2016 and Chief Financial Officer — Clinical Services Group from October 2010 until January 2013. From 2000 to 2010, Mr. Wyatt served in various capacities with Ernst & Young LLP.- Christopher F. Wyatt，他于2016年4月被任命为高级副总裁兼总会计师。此前，他曾担任公司的副总裁兼首席财务官，负责信息技术（从2013年1月到2016年4月），以及临床服务集团的首席财务官（从2010年10月到2013年1月）。从2000年到2010年，他曾担任安永会计师事务所（Ernst & Young）的多种职务。
- Christopher F. Wyatt,was appointed Senior Vice President and Controller in April 2016. Prior to that time, Mr. Wyatt served the Company as Vice President and Chief Financial Officer — IT&S from January 2013 to April 2016 and Chief Financial Officer — Clinical Services Group from October 2010 until January 2013. From 2000 to 2010, Mr. Wyatt served in various capacities with Ernst & Young LLP.
- Jennifer L. Berres
Jennifer L. Berres被任命为高级副总裁兼首席人力资源官，于2019年11月1日生效。贝瑞斯女士于1993年加入HCA，并担任过各种职务，包括从2013年4月至2019年10月担任人力资源副总裁。
Jennifer L. Berres,was appointed Senior Vice President and Chief Human Resources Officer effective November 1, 2019. Ms. Berres joined HCA in 1993 and served in various capacities, including as Vice President — Human Resources from April 2013 through October 2019.- Jennifer L. Berres被任命为高级副总裁兼首席人力资源官，于2019年11月1日生效。贝瑞斯女士于1993年加入HCA，并担任过各种职务，包括从2013年4月至2019年10月担任人力资源副总裁。
- Jennifer L. Berres,was appointed Senior Vice President and Chief Human Resources Officer effective November 1, 2019. Ms. Berres joined HCA in 1993 and served in various capacities, including as Vice President — Human Resources from April 2013 through October 2019.
- Michael R. McAlevey
Michael R. McAlevey ，于2022年1月被任命为高级副总裁兼首席法律官。在加入HCA之前，McAlevey 曾在通用电气担任高级法律和行政职务，最近一次是从2018年起担任GE Healthcare的副总裁、总法律顾问和业务发展负责人。在此之前，他曾于2011年至2018年担任通用电气航空的总法律顾问和业务发展负责人，并于2003年至2011年担任通用电气的首席企业、证券和财务顾问。在加入通用电气之前，McAlevey 曾于1998年至2002年担任美国证券交易委员会公司财务部副主任。
Michael R. McAlevey,was appointed Executive Vice President – Chief Legal and Administrative Officer of the Company, effective April 1, 2024. Mr. McAlevey previously served as Senior Vice President and Chief Legal Officer from January 2022 through March 2024. Prior to joining HCA, Mr. McAlevey served in senior legal and executive roles at General Electric, most recently as Vice President, General Counsel and Business Development Leader for GE Healthcare since 2018. Prior to that, he served as General Counsel and Business Development Leader for GE Aerospace from 2011 to 2018 and Chief Corporate, Securities and Finance Counsel for GE from 2003 to 2011. Before joining GE, Mr. McAlevey served as Deputy Director of the United States Securities and Exchange Commission's Division of Corporation Finance from 1998 to 2002.- Michael R. McAlevey ，于2022年1月被任命为高级副总裁兼首席法律官。在加入HCA之前，McAlevey 曾在通用电气担任高级法律和行政职务，最近一次是从2018年起担任GE Healthcare的副总裁、总法律顾问和业务发展负责人。在此之前，他曾于2011年至2018年担任通用电气航空的总法律顾问和业务发展负责人，并于2003年至2011年担任通用电气的首席企业、证券和财务顾问。在加入通用电气之前，McAlevey 曾于1998年至2002年担任美国证券交易委员会公司财务部副主任。
- Michael R. McAlevey,was appointed Executive Vice President – Chief Legal and Administrative Officer of the Company, effective April 1, 2024. Mr. McAlevey previously served as Senior Vice President and Chief Legal Officer from January 2022 through March 2024. Prior to joining HCA, Mr. McAlevey served in senior legal and executive roles at General Electric, most recently as Vice President, General Counsel and Business Development Leader for GE Healthcare since 2018. Prior to that, he served as General Counsel and Business Development Leader for GE Aerospace from 2011 to 2018 and Chief Corporate, Securities and Finance Counsel for GE from 2003 to 2011. Before joining GE, Mr. McAlevey served as Deputy Director of the United States Securities and Exchange Commission's Division of Corporation Finance from 1998 to 2002.
- Sammie S. Mosier
Sammie S. Mosier被任命为高级副总裁和首席执行官执行2021年12月1日生效。Mosier博士于1992加入HCA，作为法兰克福地区医疗中心的内科外科床边护士，并在2019至2021年间担任过副总裁和助理首席护理执行-临床服务小组。
Sammie S. Mosier,was appointed Senior Vice President and Chief Nurse Executive effective December 1, 2021. Dr. Mosier joined HCA in 1996 as a medical-surgical bedside nurse at Frankfort Regional Medical Center and has held progressive leadership roles, including as Vice President and Assistant Chief Nursing Executive — Clinical Services Group from 2019 to 2021.- Sammie S. Mosier被任命为高级副总裁和首席执行官执行2021年12月1日生效。Mosier博士于1992加入HCA，作为法兰克福地区医疗中心的内科外科床边护士，并在2019至2021年间担任过副总裁和助理首席护理执行-临床服务小组。
- Sammie S. Mosier,was appointed Senior Vice President and Chief Nurse Executive effective December 1, 2021. Dr. Mosier joined HCA in 1996 as a medical-surgical bedside nurse at Frankfort Regional Medical Center and has held progressive leadership roles, including as Vice President and Assistant Chief Nursing Executive — Clinical Services Group from 2019 to 2021.
- Michael A. Marks
Michael A. Marks，被任命为执行副总裁兼首席财务官，自2024年5月1日起生效。此前，他曾担任财务高级副总裁（从2023年1月到2024年4月）。从2021年3月到2022年12月，他担任财务运营支持副总裁。在此之前，他从2008年12月到2021年2月担任National Group的首席财务官，从2004年7月到2008年11月担任West Florida分部的首席财务官。他于1996年加入Hca Healthcare, Inc.。
Michael A. Marks,was appointed Executive Vice President and Chief Financial Officer, effective May 1, 2024. He previously served as Senior Vice President — Finance from January 2023 through April 2024. Mr. Marks served as Vice President — Financial Operations Support from March 2021 through December 2022. Prior to that time, he served as CFO of the National Group from December 2008 to February 2021 and CFO of the West Florida Division from July 2004 to November 2008. Mr. Marks joined HCA Healthcare in 1996.- Michael A. Marks，被任命为执行副总裁兼首席财务官，自2024年5月1日起生效。此前，他曾担任财务高级副总裁（从2023年1月到2024年4月）。从2021年3月到2022年12月，他担任财务运营支持副总裁。在此之前，他从2008年12月到2021年2月担任National Group的首席财务官，从2004年7月到2008年11月担任West Florida分部的首席财务官。他于1996年加入Hca Healthcare, Inc.。
- Michael A. Marks,was appointed Executive Vice President and Chief Financial Officer, effective May 1, 2024. He previously served as Senior Vice President — Finance from January 2023 through April 2024. Mr. Marks served as Vice President — Financial Operations Support from March 2021 through December 2022. Prior to that time, he served as CFO of the National Group from December 2008 to February 2021 and CFO of the West Florida Division from July 2004 to November 2008. Mr. Marks joined HCA Healthcare in 1996.
- Jon M. Foster
Jon M. Foster于2013年1月被任命为美国集团的总裁。在此之前，他从2011年2月到2013年1月担任西南集团的总裁，从2006年1月至2011年2月担任中央和西德克萨斯部门的部门总裁。他于2001年3月加入HCA，担任位于德克萨斯州，奥斯汀的St. David's HealthCare的总裁兼首席执行官，担任该职位直到2011年2月。在加入该公司之前，他曾在田纳西州，诺克斯维尔的Baptist Health System和在德克萨斯州，休斯顿的The Methodist Hospital System担任各种行政能力。
Jon M. Foster,was appointed Executive Vice President and Chief Operating Officer effective January 1, 2023. Prior to that time, he served as President — American Group from January 2013 to December 2022, President — Southwest Group from February 2011 to January 2013 and Division President for the Central and West Texas Division from January 2006 to February 2011. Mr. Foster joined HCA in March 2001 as President and CEO of St. David's HealthCare in Austin, Texas and served in that position until February 2011. Prior to joining the Company, Mr. Foster served in various executive capacities within the Baptist Health System in Knoxville, Tennessee and The Methodist Hospital System in Houston, Texas.- Jon M. Foster于2013年1月被任命为美国集团的总裁。在此之前，他从2011年2月到2013年1月担任西南集团的总裁，从2006年1月至2011年2月担任中央和西德克萨斯部门的部门总裁。他于2001年3月加入HCA，担任位于德克萨斯州，奥斯汀的St. David's HealthCare的总裁兼首席执行官，担任该职位直到2011年2月。在加入该公司之前，他曾在田纳西州，诺克斯维尔的Baptist Health System和在德克萨斯州，休斯顿的The Methodist Hospital System担任各种行政能力。
- Jon M. Foster,was appointed Executive Vice President and Chief Operating Officer effective January 1, 2023. Prior to that time, he served as President — American Group from January 2013 to December 2022, President — Southwest Group from February 2011 to January 2013 and Division President for the Central and West Texas Division from January 2006 to February 2011. Mr. Foster joined HCA in March 2001 as President and CEO of St. David's HealthCare in Austin, Texas and served in that position until February 2011. Prior to joining the Company, Mr. Foster served in various executive capacities within the Baptist Health System in Knoxville, Tennessee and The Methodist Hospital System in Houston, Texas.